Literature DB >> 33871960

Cancer Stem Cell-Targeted Gene Delivery Mediated by Aptamer-Decorated pH-Sensitive Nanoliposomes.

Parikshit Moitra1,2, Santosh K Misra3, Krishan Kumar3, Paturu Kondaiah4, Phuong Tran5, Wei Duan5, Santanu Bhattacharya2,3,6.   

Abstract

A new pH-responsive cationic co-liposomal formulation was prepared in this study using the twin version of the amphiphile palmitoyl homocysteine, TPHC; natural zwitterionic lipid, DOPE; and cholesterol-based twin cationic lipid, C5C, at specified molar ratios. This co-liposome was further decorated with a newly designed fluorescently tagged, cholesterol-tethered EpCAM-targeting RNA aptamer for targeted gene delivery. This aptamer-guided nanoliposomal formulation, C5C/DOPE/TPHC at 8:24:1 molar ratio, could efficiently transport the genes in response to low pH of cellular endosomes selectively to the EpCAM overexpressing cancer stem cells. This particular observation was extended using siRNA against GFP to validate their transfection capabilities in response to EpCAM expression. Overall, the aptamer-guided nanoliposomal formulation was found to be an excellent transfectant for in vitro siRNA gene delivery.

Entities:  

Keywords:  EpCAM overexpression; aptamer; cancer stem cells; cationic co-liposome; pH sensitivity; targeted gene delivery

Year:  2021        PMID: 33871960     DOI: 10.1021/acsbiomaterials.1c00110

Source DB:  PubMed          Journal:  ACS Biomater Sci Eng        ISSN: 2373-9878


  3 in total

Review 1.  Nanoliposomes in Cancer Therapy: Marketed Products and Current Clinical Trials.

Authors:  Raquel Taléns-Visconti; Octavio Díez-Sales; Jesus Vicente de Julián-Ortiz; Amparo Nácher
Journal:  Int J Mol Sci       Date:  2022-04-12       Impact factor: 6.208

Review 2.  Non-Viral Vectors for Delivery of Nucleic Acid Therapies for Cancer.

Authors:  Shrey Kanvinde; Tanmay Kulkarni; Suyash Deodhar; Deep Bhattacharya; Aneesha Dasgupta
Journal:  BioTech (Basel)       Date:  2022-03-07

Review 3.  Encapsulation of miRNA and siRNA into Nanomaterials for Cancer Therapeutics.

Authors:  Mina Zare; Rakesh Pemmada; Maya Madhavan; Aswathy Shailaja; Seeram Ramakrishna; Sumodan Padikkala Kandiyil; James M Donahue; Vinoy Thomas
Journal:  Pharmaceutics       Date:  2022-08-03       Impact factor: 6.525

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.